{"id":"W1571042765","doi":"10.1016/s0079-6468(08)70095-x","title":"5 Discovery of Montelukast: a Once-a-Day Oral Antagonist of Leukotriene D4 for the Treatment of Chronic Asthma","year":2001,"lang":"en","type":"review","venue":"Progress in medicinal chemistry","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Montelukast; Leukotriene; Leukotriene C4; Cysteine; Pharmacology; Chemistry; Asthma; Arachidonic acid; Peptide; Antagonist; Medicine; Biochemistry; Immunology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004990924,0.0008029179,0.001195784,0.001746735,0.0003135133,0.001051367,0.0009477414,0.001309529,0.00344901],"category_scores_gemma":[0.0003059396,0.0003289149,0.0005870557,0.001273803,0.0003161088,0.001170301,0.000461314,0.001315702,0.002819781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008282267,"about_ca_system_score_gemma":0.0009421603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009131643,"about_ca_topic_score_gemma":0.002109245,"domain_scores_codex":[0.9998584,0.00001687539,0.00001623065,0.00002216663,0.00006301914,0.0000232711],"domain_scores_gemma":[0.9998937,0.00002427865,0.00002256149,0.000004219818,0.00003490589,0.00002041373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004656755,0.0002248195,0.0001943998,0.01065025,0.0001258799,0.001063132,0.0001030477,0.0006290731,0.02841875,0.004975953,0.036655,0.9164941],"study_design_scores_gemma":[0.0001353187,0.0004168951,0.0009884447,0.0009898138,0.0001691919,0.002494781,0.00003634565,0.0002896735,0.007609966,0.001264331,0.9855776,0.00002769011],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002061944,0.991536,0.0008718296,0.0006352607,0.0008494217,0.00002713923,0.00008143467,0.00003638797,0.003900502],"genre_scores_gemma":[0.006657516,0.982647,0.0015449,0.0009716985,0.0004337093,0.00001944477,0.0002300394,0.000006135624,0.007489476],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00344901,"threshold_uncertainty_score":0.01153815,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03979264609060039,"score_gpt":0.3694329923754681,"score_spread":0.3296403462848677,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}